Dashboard
Manage Tickers

RCKT ROCKET PHARMACEUTICALS, INC.

Nasdaq rocketpharma.com


$ 3.29 $ -0.20 (-5.73 %)    

Tuesday, 04-Nov-2025 19:39:47 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ 3.29
$ 3.49
$ 3.28 x 5
$ 3.68 x 5
$ 3.28 - $ 3.53
$ 2.19 - $ 18.17
1,691,713
na
355M
$ 1.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 02-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-05-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-05-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-06-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-08-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-11-2018 03-31-2018 10-Q
32 03-07-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-16-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-10-2016 06-30-2016 10-Q
39 05-11-2016 03-31-2016 10-Q
40 03-23-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fdas-rigid-approach-adds-uncertainty-to-uniqures-accelerated-pathway-for-huntingtons-gene-therapy
FDA's Rigid Approach Adds Uncertainty To u...
11/04/2025 19:25:08

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval ...

fda-acceptance-of-rocket-pharmaceuticals-lead-gene-therapy-application-reestablishes-momentum-for-stock
FDA Acceptance Of Rocket Pharmaceuticals' ...
10/14/2025 18:27:11

FDA accepts Rocket Pharmaceuticals' resubmission for Kresladi gene therapy in severe LAD-I, with a decision expected by Mar...

chardan-capital-maintains-buy-on-rocket-pharmaceuticals-maintains-11-price-target
Chardan Capital Maintains Buy on Rocket Ph...
10/14/2025 18:02:15

Chardan Capital analyst Geulah Livshits maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy and maintains $11 price ta...

dominos-pizza-posts-upbeat-results-joins-astria-therapeutics-albertsons-companies-polaris-and-other-big-stocks-moving-higher-on-tuesday
Domino's Pizza Posts Upbeat Results, Joins...
10/14/2025 14:15:51

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/14/2025 12:09:03

the-fda-has-accepted-the-resubmission-of-rocket-pharmaceuticals-marketing-application-for-kresladi-marnetegragene-autotemcel-marne-cel-an-investigational-gene-therapy-for-severe-leukocyte-adhesion-deficiency-i-pdufa-date-is-march-28-2026
The FDA Has Accepted The Resubmission Of R...
10/14/2025 11:12:08

Prescription Drug User Fee Act (PDUFA) target action date is March 28, 2026All primary and secondary endpoints were met, and KR...

leerink-partners-maintains-market-perform-on-rocket-pharmaceuticals-lowers-price-target-to-7
Leerink Partners Maintains Market Perform ...
10/03/2025 15:15:20

Leerink Partners analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Market Perform and lowers the p...

rocket-pharmaceuticals-voluntarily-withdraws-bla-for-investigational-gene-therapy-mozafancogene-autotemcel-fanskya-for-fanconi-anemia
Rocket Pharmaceuticals Voluntarily Withdra...
10/03/2025 11:06:16

fda-outlines-process-to-speed-up-rare-disease-therapy-approvals
FDA Outlines Process To Speed Up Rare Dise...
09/04/2025 18:50:03

FDA launches Rare Disease Evidence Principles to guide therapy reviews, offering new pathways for approval while raising questi...

rocket-pharmaceuticals-cfo-aaron-ondrey-resigns-martin-wilson-appointed-interim-cfo-effective-september-8
Rocket Pharmaceuticals CFO Aaron Ondrey Re...
08/25/2025 20:35:20

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangemen...

the-european-medicines-agency-just-disclosed-that-rocket-pharmaceuticals-has-withdrawn-its-application-for-marketing-authorization-of-fanskya-the-ema-concluded-that-the-benefit-of-mozafancogene-autotemcel-did-not-outweigh-its-risks---ema
'The European Medicines Agency Just Disclo...
08/22/2025 18:45:15

https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-withdrawal-application-marketing-authorisation-fanskya-moz...

coty-bilibili-canadian-solar-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Coty, Bilibili, Canadian Solar And Other B...
08/21/2025 12:19:50

why-nordson-shares-are-trading-higher-by-over-5-here-are-20-stocks-moving-premarket
Why Nordson Shares Are Trading Higher By O...
08/21/2025 09:23:30

b-of-a-securities-upgrades-rocket-pharmaceuticals-to-buy-raises-price-target-to-10
B of A Securities Upgrades Rocket Pharmace...
08/20/2025 17:59:37

B of A Securities analyst Jason Zemansky upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) from Neutral to Buy and raises the pr...

chardan-capital-maintains-buy-on-rocket-pharmaceuticals-maintains-11-price-target
Chardan Capital Maintains Buy on Rocket Ph...
08/20/2025 15:59:50

Chardan Capital analyst Geulah Livshits maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy and maintains $11 price ta...

tjx-posts-better-than-expected-earnings-joins-rocket-pharmaceuticals-guess-and-other-big-stocks-moving-higher-on-wednesday
TJX Posts Better-Than-Expected Earnings, J...
08/20/2025 13:58:29

fda-lifts-rocket-pharmaceuticals-study-hold-for-rare-disease-gene-therapy
FDA Lifts Rocket Pharmaceuticals Study Hol...
08/20/2025 13:31:04

Rocket Pharmaceuticals shares rise after FDA clears its pivotal RP-A501 trial for Danon disease with adjusted dosing and update...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/20/2025 12:08:41

why-rocket-pharmaceuticals-shares-are-trading-higher-by-over-15-here-are-20-stocks-moving-premarket
Why Rocket Pharmaceuticals Shares Are Trad...
08/20/2025 11:24:03

the-fda-lifts-clinical-hold-on-rocket-pharmaceuticals-pivotal-phase-2-trial-of-rp-a501-for-danon-disease
The FDA Lifts Clinical Hold On Rocket Phar...
08/20/2025 11:05:39

In its correspondence, the FDA confirmed that Rocket satisfactorily addressed issues outlined in the clinical hold. The FDA aut...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION